Oncology & Cancer

Short-, long-course therapy comparable in T3 rectal cancer

(HealthDay)—There are no statistically significant differences in the rates of local recurrence (LR), distant recurrence, relapse-free survival, overall survival, or late toxicity in patients treated with short-course (SC) ...

Oncology & Cancer

Reducing the side effects of treatment for prostate cancer

New research published in BioMed Central's open access journal BMC Medicine reassessing clinical data from trials, which investigate ways of treating side effects of therapy for prostate cancer, finds that tamoxifen, an anti-estrogen ...

Oncology & Cancer

Older women may not benefit from radiotherapy after breast surgery

A Rhode Island Hospital radiation oncologist says in a new editorial that research exploring the impact of radiotherapy in older women with low risk of breast cancer recurrence has little effect on actual clinical decisions. ...

Oncology & Cancer

A promising step forward in prostate cancer treatment

When treating prostate cancer with radiotherapy, knowing the prostate cancer position is critical to accurately targeting the radiation beam to avoid missing the tumour and irradiating healthy tissue. Prostate cancer patients ...

Oncology & Cancer

Induction chemo beneficial in locally advanced pancreatic CA

(HealthDay) -- For most patients with locally advanced pancreatic carcinoma (LAPC), induction with a combination of gemcitabine and oxaliplatin (GEMOX) followed by chemoradiotherapy (CRT) is feasible, resulting in clinical ...

Oncology & Cancer

Pre-op chemoradiotherapy ups survival in esophageal cancer

(HealthDay) -- For patients with esophageal or esophagogastric-junction cancer, treatment with neoadjuvant chemoradiotherapy followed by surgical resection is associated with improved survival compared with surgery alone, ...

page 26 from 33